JB Pharma Second ESG Report for FY 2022-23: A Sustainable Journey

In an era where environmental sustainability, corporate responsibility, and ethical practices are at the forefront of business operations, JB Pharma has once again taken a bold step forward. The pharmaceutical giant recently published its second Sustainability (ESG) Report for the fiscal year 2022-23, showcasing impressive progress in various key areas. This report is not just a mere document; it’s a testament to JB Pharma’s commitment to making the world a better place.

JB Pharma
JB Pharma

Reducing GHG Intensity: A Remarkable Achievement

One of the standout achievements highlighted in JB Pharma’s ESG report is the significant reduction in Green House Gas (GHG) intensity. Compared to the previous year, JB Pharma has successfully reduced its GHG emissions by an impressive 19 percent. This reduction encompasses both Scope 1 and Scope 2 emissions, underlining the company’s dedication to curbing its carbon footprint.

Scope 3 Emissions Calculation: A Pioneering Move

In a pioneering move towards greater transparency and accountability, JB Pharma has ventured into calculating Scope 3 emissions for the first time. This calculation includes not only emissions within the organization but also throughout the external supply chain. This holistic approach aligns with the company’s commitment to responsible business practices and sustainability.

Embracing Renewable Energy Sources

To contribute to a cleaner and greener future, JB Pharma has initiated the use of renewable hybrid power supplies, including wind and solar energy, in all its manufacturing facilities in India. This green energy initiative has resulted in the generation of an impressive 8464.89 GJ of energy from sustainable sources. JB Pharma’s dedication to renewable energy showcases its responsibility towards the environment and the community.

ESG Aligned with International Standards

Nikhil Chopra, CEO & Whole Time Director of JB Pharma, emphasizes the importance of ESG in today’s dynamic business environment. The second ESG report adheres to international reporting frameworks, primarily the Global Reporting Initiative (GRI) and aligns with the United Nations Sustainable Development Goals (UN SDGs). This ensures that JB Pharma’s sustainability efforts are on par with global best practices.

A Commitment to Water Conservation

JB Pharma’s commitment to responsible water usage is evident in the treatment of nearly forty thousand liters of water through Effluent Treatment Plants (ETP). This treated water is then reused within the manufacturing sites, contributing to zero liquid discharge. Such initiatives reflect JB Pharma’s dedication to water conservation and reducing its ecological impact.

Effective Waste Management

Waste management is a critical aspect of sustainability. JB Pharma has demonstrated its commitment to reducing waste by diverting 93.6 percent of non-hazardous waste from disposal. Furthermore, there has been a notable 32.4 percent decrease in hazardous waste sent to landfills. These efforts signify the company’s drive to minimize its environmental footprint.

Fostering Employee Well-being and Diversity

JB Pharma’s commitment to sustainability extends to its employees. The introduction of JB Cares, a comprehensive in-house wellness app, reflects the company’s dedication to the physical and mental well-being of its workforce. Moreover, JB Pharma has implemented a continuous learning and development framework known as I.D.E.A., which includes leadership development, talent development, and upskilling programs. These initiatives contribute to employees’ personal and organizational growth.

Promoting Gender Diversity

JB Pharma takes pride in its commitment to gender diversity. Since 2019-20, there has been a remarkable 14.4 percent increase in women’s representation within the organization. This includes a 14 percent increase in women’s representation across fields that were historically dominated by their male counterparts in the industry. JB Pharma’s efforts to bridge gender gaps serve as an inspiring example for the pharmaceutical sector.

Nurturing Diversity, Equity, and Inclusion

JB Pharma is actively working on drafting a charter and framework for Diversity, Equity, and Inclusion (DE&I). This initiative aims to nurture talent and create equal opportunities within the organization. It underscores JB Pharma’s commitment to fostering a diverse and inclusive workplace where every individual’s potential is valued.

In conclusion, JB Pharma’s second ESG report for FY 2022-23 showcases its remarkable commitment to sustainability, responsible business practices, and employee well-being. From reducing GHG intensity to embracing renewable energy, the company is making significant strides towards a greener future. JB Pharma’s dedication to gender diversity and inclusion further solidifies its reputation as a progressive and responsible pharmaceutical leader.

FAQs

1. What is the significance of Scope 3 emissions calculation in JB Pharma’s ESG report?

Calculating Scope 3 emissions represents JB Pharma’s commitment to transparency and accountability, as it includes emissions throughout the external supply chain, not just within the organization.

2. How has JB Pharma contributed to reducing its carbon footprint?

JB Pharma has reduced its Green House Gas (GHG) intensity by 19 percent, encompassing both Scope 1 and Scope 2 emissions, a significant achievement in reducing its carbon footprint.

3. What initiatives has JB Pharma taken to promote employee well-being?

JB Pharma has introduced JB Cares, an in-house wellness app, and implemented a continuous learning and development framework (I.D.E.A.) to enhance the physical and mental well-being of its employees.

4. How is JB Pharma addressing gender diversity within the organization?

JB Pharma has witnessed a 14.4 percent increase in women representation since 2019-20, with a 14 percent increase in traditionally male-dominated fields, demonstrating its commitment to gender diversity.

5. What is JB Pharma’s approach to Diversity, Equity, and Inclusion (DE&I)?

JB Pharma is actively working on a charter and framework for DE&I, aiming to create equal opportunities and nurture talent within the organization.

also read Tata Nexon EV with Amazing Features and Impressive Range

Leave a comment